<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221116056519N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-18</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Tourniquet effects on knee joint replacement</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of amount of bone cement penetration and short-term outcomes in total knee arthroplasty with and without the use of tourniquets</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67048</url>
      <study_type>observational</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization by the method of 2 blocks and individually by the site randomization.com, done by a person outside the study and informed to the operating room personnel without the surgeon's knowledge, Blinding description: Randomization is done by a third person outside the study, and on the day of the surgery, another person outside the surgery, who is from the operating room staff, is informed, and the data is performed by another third party. It is collected without the knowledge of the surgeon. Data analysis is done by another person who is outside the study in 2 separate groups without knowing the type of intervention. At the beginning of the study, the type of intervention was explained to all patients, and consent was obtained, but the patient was unaware of the type of randomization.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The amount of cement penetration, the amount of bleeding after surgery, pain after surgery, the function of muscles around the knee after surgery, the amount of knee ROM after surgery, the relationship between BMD and cement penetration in TKA.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: patients who do not use a tourniquet to perform TKA. ZIMMER and DEPUY prostheses are used. Patients are examined for muscle strength, knee joint range of motion, and bone density measurements. Check HB. Intervention 2: Control group: patients who use a tourniquet to perform TKA. ZIMMER and DEPUY prostheses are used. Patients are examined for muscle strength, knee joint range of motion, and bone density measurements. They are also subjected to a CBC test. Check HB.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After de-identifying people, the entire data can be shared and published as a file

When:
The access period starts 9 months after the results are published

To whom:
People working in academic and scientific centers will have access to the file

Conditions:
The data are for designing future studies and are allowed to be used

Where to obtain:
hesan rezaee
00989128651586
hesan.rezaee@gmail.com

How to obtain:
Along with the request, a summary of the academic and professional degree and the university center where the student is employed should be sent. The data file will be sent within 2 weeks at most.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hesan Rezaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>no 26, Mohammadi St, Amirloo Ave, Towhid square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419743375</zip>
        <telephone>+98 21 2214 7706</telephone>
        <email>hesan.rezaee@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hesan Rezaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No26,mohammadi st,amirloo st , Tohid square, tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419743375</zip>
        <telephone>+98 21 2169 2614</telephone>
        <email>hesan.rezaee@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis and confirmation of indications for total knee arthroplasty surgery
55 to 85 years old
BMI &lt; 45
osteoarthritis with 3 score in kellgren and lawrence
ASA score 1 or 2
TKA with Nextgen Zimmer Biomet or DePuy prosthesis
primary TKA</inclusion_criteria>
      <agemin>55 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>previous knee fracture or surgery
malignancy
rheumatoid diseases
cardiovascular diseases
infectious diseases
neurologic diseases
hepatic failure disease
coagulopathy disorders
glucocorticoid or heparin or warfarin consumption
previous history of DVT or PTE
neuromuscular diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: patients who do not use a tourniquet to perform TKA. ZIMMER and DEPUY prostheses are used. Patients are examined for muscle strength, knee joint range of motion, and bone density measurements. Check HB.</i_keyword>
      <i_keyword>Control group: patients who use a tourniquet to perform TKA. ZIMMER and DEPUY prostheses are used. Patients are examined for muscle strength, knee joint range of motion, and bone density measurements. They are also subjected to a CBC test. Check HB.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Comparing the amount of cement penetration around the prosthesis in patients who undergo TKA surgery with and without the use of a tourniquet. Timepoint: 60 days after surgery, AP and LAT radiographs of the knee were taken, and based on the criteria of the Knee Society Radiographic Evaluation System, cement penetration was calculated in millimeters. Method of measurement: According to the Knee Society Radiographic Evaluation System in AP/Lat radiographs of the knee.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Hemoglobin reduction rate after surgery. Timepoint: Hemoglobin level is measured before surgery and then on days 1, 7, 14, 60. Method of measurement: Based on cbc test and in gr/dl.</sec_outcome>
      <sec_outcome>Body size changes. Timepoint: It is measured before surgery and then on days 1, 7, 14, 60. Method of measurement: In 2 places, 5 cm above the medial malleolus and 10 cm above the superior patella, the limb circumference is measured.</sec_outcome>
      <sec_outcome>Knee range of motion. Timepoint: It is measured before surgery and then on days 1, 7, 14, 60. Method of measurement: in degrees and using goniometr.</sec_outcome>
      <sec_outcome>Knee pain. Timepoint: It is measured before surgery and then on days 1, 7, 14, 60. Method of measurement: Based on the Visual Analogue Scale.</sec_outcome>
      <sec_outcome>Strength of knee extensor and flexor muscles. Timepoint: It is measured before surgery and then on days 1, 7, 14, 60. Method of measurement: Clinical examination of muscle strength.</sec_outcome>
      <sec_outcome>Post operation complications. Timepoint: Day 1,7,14,60. Method of measurement: Presence or absence of dvt/pte/bleeding/infection.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-19</approval_date>
        <contact_name>Research Ethics Committees of Imam Khomeini Hospital Complex- Tehran University of Medical Sciences</contact_name>
        <contact_address>imam khomeini hospital,doctor gharib street,keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
